Viceroy Hotels consol PAT falls 49% YoY to ₹2.23 Cr as capex costs offset revenue gains
PAT -49.1% YoY · revenue +56.52% · margins compressing
₹48.2 Cr
+56.52% YoY
₹2.23 Cr
-49.1% YoY
4.57%
-9.2pp YoY
₹0.34
Viceroy Hotels' consolidated (primary basis) PAT fell 49.1% YoY to ₹2.23 Cr in Q2 FY27, even as consolidated revenue rose 56.5% YoY to ₹48.20 Cr — but that revenue growth is not like-for-like: the company's own filing notes confirm the year-ago consolidated comparative excluded subsidiary SLN Terminus & Resorts, now consolidated for the first time. On a standalone (organic, comparable-entity) basis, revenue grew a more modest 13.9% YoY to ₹35.07 Cr while PAT fell 59.5% YoY to ₹1.78 Cr — the cleaner read of the underlying business. No formal analyst/brokerage coverage or consensus estimate for this quarter turned up in a search (a small, thinly-covered name), so vs-street is unknown.
Q2 FY-2027 vs prior quarters
The profit decline is a below-the-line story, not an operating one: OPM (EBITDA/revenue) held roughly flat at ~25.5% consolidated versus ~25.2% a year ago, but NPM collapsed to 4.57% from 13.75%. Finance costs more than quadrupled to ₹5.79 Cr (consolidated) from ₹1.10 Cr, and depreciation rose 77% to ₹6.08 Cr from ₹3.43 Cr, both consistent with the ongoing Phase 2 capex programme management has flagged. Complicating the read further, standalone other income jumped to ₹3.66 Cr from ₹1.06 Cr a year ago — an amount that closely tracks the ₹3.55 Cr cross-subsidy surcharge litigation win the company disclosed on Sep 10, 2026. The filing does not break out other income, so this cannot be confirmed with certainty, but if that gain sits inside this quarter's other income, standalone pre-tax profit of just ₹0.42 Cr is largely or wholly a function of a one-off, and underlying standalone profitability would be close to breakeven or a loss. Consolidated other income is far smaller (₹0.59 Cr), implying intercompany items are eliminated on consolidation — standalone and consolidated other-income composition diverge materially this quarter.
The stock went into the print at ₹147.9, down 0.1% over the past month of trading.
EBITDA margin target above 30% near-term; long-term benchmark 40%. Courtyard ADR to reach 6,800-8,500 (potentially 9,000-9,500) over 2 years at 80-85% occupancy. Phase 2 completion Q3 FY27; Madhapur operational FY29-30. Expect to beat prior-year quarters despite Q1-Q2 seasonal weakness and ₹10 Cr EBITDA displacement fr
— This quarter: missed
Against management's own Q1 FY27 concall guidance — EBITDA margin above 30% near-term, and an expectation to 'beat prior-year quarters despite Q1-Q2 seasonal weakness' — this quarter missed on both counts: OPM is still in the mid-20s% and PAT fell YoY on both bases. The ₹105.83 Cr rights issue (92.03 lakh shares at ₹115, allotted Sep 15, 2026) raised funds explicitly for debt repayment, a partial offset to the capex-driven finance-cost surge, while promoter holding was diluted to 74.03% as a result. Sequentially, consolidated PAT rose 54% QoQ and revenue 7.4% QoQ, but Q1-Q2 is hotels' seasonally soft window, so this reads as a low-base recovery rather than a turnaround. Looking ahead, a novation agreement effective Oct 1, 2026 shifts the Marriott Executive Apartments operating agreement from subsidiary SLN Terminus back onto the holding company's own books — which will again change the standalone/consolidated comparison from Q3 FY27, around when management has guided for Phase 2 completion.
W1
Finance cost/depreciation run-rate (₹5.79 Cr / ₹6.08 Cr this quarter, consolidated) once Phase 2 capex completes in Q3 FY27, per management's own timeline.
W2
OPM trajectory toward management's >30% near-term EBITDA margin target — currently ~25.5% consolidated, ~19.7% standalone.
W3
Standalone/consolidated comparability from Q3 FY27 after the Oct 1, 2026 MEA novation moves those operations back onto the holding company's books.